Dolby Laboratories Quarterly Cash Flow Statement
NYSE: DLBMiscellaneousMulti-Sector CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dolby Laboratories free cash flow
In the quarter ended Jun 26, 2026, Dolby Laboratories generated $167.5 million of operating cash flow and spent $15.0 million on capital expenditures. That left free cash flow of $152.5 million, a free-cash-flow margin of 50.0% of revenue. Free cash flow was up 148.9% from the prior year's $61.3 million.
Dolby Laboratories returned $99.0 million to shareholders: $34.0 million in dividends and $65.0 million in share repurchases, equal to 65% of free cash flow. Free cash flow covered dividend payments 4.5 times.
Summary generated from market data by MetaCap's automated system. Methodology
Dolby Laboratories cash flow statement (quarterly)
| Quarter (USD) | Q3 20262026-06-26 | Q2 20262026-03-27 | Q1 20262025-12-26 | Q4 20252025-09-26 | Q3 20252025-06-27 | Q2 20252025-03-28 | Q1 20252024-12-27 | Q4 20242024-09-27 | Q3 20242024-06-28 | Q2 20242024-03-29 | Q1 20242023-12-29 | Q4 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 29.21M | 95.45M | 53.68M | 49.65M | 46.54M | 92.23M | 68.07M | 58.87M | 39.66M | 98.21M | 67.58M | 9.91M |
| Net Income growth (YoY) | -37.23% | +3.50% | -21.14% | -15.65% | +17.37% | -6.10% | +0.72% | +494.13% | +141.73% | +2.43% | -14.94% | -64.31% |
| Depreciation & Amortization | 22.60M | 24.10M | 24.14M | 22.00M | 21.93M | 21.54M | 22.36M | 21.36M | 18.31M | 18.02M | 17.87M | 21.13M |
| Stock-Based Compensation | 30.96M | 30.71M | 37.21M | 31.05M | 30.73M | 30.66M | 36.07M | 29.68M | 29.34M | 28.91M | 31.89M | 28.20M |
| Change in Working Capital | 56.95M | -8.89M | -34.83M | 25.33M | -58.33M | 56.84M | -1.28M | 24.51M | -116.19M | 79.23M | -65.47M | 16.17M |
| Operating Cash Flow | 167.46M | 92.51M | 54.80M | 122.83M | 67.69M | 174.90M | 106.78M | 116.17M | 21.26M | 181.41M | 8.41M | 85.02M |
| Capital Expenditures | -14.99M | -9.06M | -4.63M | -16.24M | -6.43M | -6.90M | -6.78M | -7.38M | -7.61M | -8.92M | -6.10M | -8.19M |
| Investing Cash Flow | -9.79M | -46.09M | 1.25M | -21.91M | -6.43M | 25.89M | -8.14M | -261.31M | -7.74M | -17.87M | 633.00K | -19.71M |
| Dividends Paid | -33.98M | -34.34M | -34.34M | -31.59M | -31.63M | -31.83M | -31.55M | -28.61M | -28.70M | -28.72M | -28.55M | -25.82M |
| Share Repurchases | -65.00M | -65.00M | -70.00M | -35.00M | -70.00M | -35.00M | -15.00M | -20.00M | -35.00M | -25.00M | -80.00M | -25.00M |
| Financing Cash Flow | -91.02M | -99.88M | -121.83M | -64.06M | -60.74M | -64.87M | -57.57M | -60.12M | -58.40M | -44.16M | -125.14M | -42.80M |
| Net Change in Cash | 65.08M | -53.76M | -65.80M | 36.80M | 6.22M | 138.69M | 33.91M | -200.87M | -45.73M | 115.70M | -109.31M | 18.81M |
| Free Cash Flow | 152.47M | 83.44M | 50.17M | 106.59M | 61.26M | 168.00M | 100.00M | 108.79M | 13.65M | 172.49M | 2.31M | 76.83M |
This table shows 12 quarterly periods of Dolby Laboratories's cash flow statement, from Q3 2026 back to Q4 2023, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow DLB's reporting calendar. What is a cash flow statement?